MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 23 filers reported holding MOLECULIN BIOTECH INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $0 | – | 1 | -99.7% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 394 | -73.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 1,460 | -29.6% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 2,073 | +0.0% | 0.00% | – |
Q3 2019 | $2,000 | +100.0% | 2,072 | +107.2% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 1,000 | -4.1% | 0.00% | – |
Q3 2018 | $2,000 | – | 1,043 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Acrospire Investment Management LLC | 1,600 | $9,000 | 0.01% |
Virtu KCG Holdings LLC | 11,614 | $66,000 | 0.00% |
ING GROEP NV | 20,000 | $122,000 | 0.00% |
NEXT Financial Group, Inc | 500 | $3,000 | 0.00% |
Tower Research Capital LLC (TRC) | 917 | $5,000 | 0.00% |
CITIGROUP INC | 5,000 | $29,000 | 0.00% |
MORGAN STANLEY | 700 | $4,000 | 0.00% |
WFG Advisors, LP | 400 | $2,000 | 0.00% |
UBS Group AG | 2,495 | $14,000 | 0.00% |